M. Joycelyn Elders rose to prominence as an influential pediatrician and public health advocate. Throughout her storied career, Dr. Elders served as the first black woman appointed Surgeon General of the United States, pioneering groundbreaking advancements in adolescent health education. Her inspiring dedication to promoting health equality, education, and women's rights has solidified her legacy as a trailblazing leader in the healthcare sector.
Dr. Elders, born August 13, 1933, in Schaal, Arkansas, displayed extraordinary intellect from a young age. After high school, she attended Philander Smith College in Little Rock. After her undergraduate program, she enlisted in the army and attended Brooke Army Medical Center and the physical therapy program. Upon her discharge in 1956, she attended the University of Arkansas Medical School.
After completing her residency in pediatrics, Dr. Elders joined the faculty at the University of Arkansas Medical School, rising to Professor and Chairperson of the Department of Pediatrics. Among her many accomplishments, she founded the Arkansas Minority Medical Education Program, aimed at recruiting minority students into healthcare professions.
Her rise to national prominence began in 1987 when Governor Bill Clinton appointed her Surgeon General of Arkansas, a position she held until 1993. During her tenure, she implemented nationally renowned programs tackling teen pregnancy and sexually transmitted infections.
Following Clinton's presidential election, Dr. Elders assumed the role of Surgeon General of the United States in 1993, becoming the first African American and second woman to occupy the position. As Surgeon General, she championed controversial issues such as HIV/AIDS, tobacco control, and adolescent sexual health education. Unfortunately, Dr. Elders' bold stance on controversial topics sparked intense opposition from conservative politicians and religious leaders and, in 1994, she resigned from her position as Surgeon General.
In 1995, Dr. Elders continued her work with the University of Arkansas as a faculty researcher and a professor of pediatric endocrinology at the Arkansas Children's Hospital.
Dr. Elders' tireless efforts to destigmatize taboo health topics and broaden access to education laid the foundation for modern health discussions. Through her courage and determination, she challenged societal norms and galvanized meaningful change in healthcare. The legacy of Dr. Joycelyn Elders lives on as an inspiration for future generations of healthcare professionals and activists.
Sources:
For sponsors developing new therapies, one of the most critical milestones on the regulatory pathway is preparing and submitting a New Drug Application (NDA). While biologics require a Biologics License Application (BLA), small-molecule drugs follow the NDA process.
The BLA is more than just an administrative step. It is the culmination of years of research, development, manufacturing, and clinical testing, and it represents the sponsor’s formal request that the FDA approve a biologic for commercial distribution in the United States.
Whether you’re submitting to the FDA, EMA, or another authority, the CSR must tell a clear, compliant, and credible story of your trial. GLOBAL's Medical Writing team shares tips and tricks to get it right.
